Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immuneering Corp

3.57
+0.14004.08%
Post-market: 3.50-0.0700-1.96%19:00 EDT
Volume:228.56K
Turnover:793.49K
Market Cap:128.47M
PE:-1.82
High:3.58
Open:3.38
Low:3.37
Close:3.43
Loading ...
Mar 06, 2023

Major Issues Report

8-K - Current report
Mar 06, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 10, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 19, 2022

Major Issues Report

8-K/A [Amend] - Current report
Aug 17, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 10, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 25, 2022

Major Issues Report

8-K - Current report
Jun 24, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 10, 2022

Major Issues Report

8-K - Current report
Mar 10, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 18, 2022

Major Issues Report

8-K - Current report